Source:http://linkedlifedata.com/resource/pubmed/id/12445536
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2002-11-26
|
pubmed:abstractText |
Heart failure and left ventricular systolic dysfunction (LVSD) are increasingly common disorders, with outcomes worse than many cancers. Evidence-based therapies, such as ACE inhibitors and beta-blockers, improve prognosis and symptoms, and reduce healthcare expenditure. However, despite the high prevalence and malignant prognosis, few studies have reported the impact of heart failure and LVSD on overall quality of life and, more crucially, have not researched the elderly or those in the community.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1867-76
|
pubmed:dateRevised |
2007-11-15
|
pubmed:articleTitle |
Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population.
|
pubmed:affiliation |
Department of Primary Care and General Practice, Primary Care Clinical Sciences Building, University of Birmingham, Birmingham B15 2TT, U.K.
|